|Bid||0.00 x 2900|
|Ask||0.00 x 800|
|Day's Range||2.01 - 2.22|
|52 Week Range||1.82 - 7.69|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sunesis to Host Conference Call Today at 4:30 PM Eastern Time. SOUTH SAN FRANCISCO, Calif., May 08, 2018-- Sunesis Pharmaceuticals, Inc. today reported financial results for the first quarter ended March ...
Sunesis Pharmaceuticals, Inc. (SNSS) today announced that it will host a conference call on Tuesday, May 8th, 2018 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2018. To access the live audio webcast, or the subsequent archived recording, visit the "Investors and Media - Calendar of Events" section of the Sunesis website at http://ir.sunesis.com. The webcast will be recorded and available for replay on the company's website for two weeks.
NEW YORK, NY / ACCESSWIRE / March 8, 2018 / Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) will be discussing their earnings results in their Q4 Earnings Call to be held on March 8, 2018, at 4:30 PM Eastern ...
LONDON, UK / ACCESSWIRE / November 16, 2017 / Sunesis (NASDAQ: SNSS) remains on track to complete the dose-escalation portion of its Phase Ib/II clinical trial for lead compound SNS-062, an oral Bruton's ...